S
TXG icon

SignatureFD’s 10x Genomics TXG Stock Holding History

SignatureFD’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Sell
2,697
-84
-3% -$2.2K ﹤0.01% 1424
2026
Q1 		$59K Buy
2,781
+148
+6% +$2.96K ﹤0.01% 1636
2025
Q4 		$42.9K Buy
2,633
+33
+1% +$499 ﹤0.01% 1741
2025
Q3 		$30.4K Hold
2,600
– – ﹤0.01% 1903
2025
Q2 		$30.1K Sell
2,600
-1,603
-38% -$14.6K ﹤0.01% 1871
2025
Q1 		$36.7K Buy
4,203
+2,409
+134% +$30.4K ﹤0.01% 1744
2024
Q4 		$25.8K Buy
1,794
+1,452
+425% +$22.9K ﹤0.01% 1934
2024
Q3 		$7.72K Buy
342
+215
+169% +$4.45K ﹤0.01% 2439
2024
Q2 		$2.47K Sell
127
-62
-33% -$1.62K ﹤0.01% 2707
2024
Q1 		$7.09K Sell
189
-38
-17% -$1.67K ﹤0.01% 2432
2023
Q4 		$12.7K Sell
227
-104
-31% -$4.53K ﹤0.01% 2149
2023
Q3 		$13.7K Sell
331
-6
-2% -$312 ﹤0.01% 2042
2023
Q2 		$18.8K Buy
337
+40
+13% +$2.17K ﹤0.01% 1924
2023
Q1 		$16.6K Buy
297
+102
+52% +$4.76K ﹤0.01% 1969
2022
Q4 		$7.11K Buy
195
+110
+129% +$3.6K ﹤0.01% 2291
2022
Q3 		$2K Sell
85
-187
-69% -$7.12K ﹤0.01% 2853
2022
Q2 		$12K Buy
272
+165
+154% +$8.56K ﹤0.01% 2048
2022
Q1 		$8K Buy
107
+25
+30% +$2.19K ﹤0.01% 2292
2021
Q4 		$12K Buy
82
+72
+720% +$11K ﹤0.01% 2048
2021
Q3 		$1K Buy
10
+4
+67% +$687 ﹤0.01% 2936
2021
Q2 		$1K Buy
6
+1
+20% +$181 ﹤0.01% 2843
2021
Q1 		$1K Buy
+5
New +$863 ﹤0.01% 2689
2020
Q4 		– Sell
-12
Closed -$1K – 2706
2020
Q3 		$1K Sell
12
-2
-14% -$210 ﹤0.01% 2510
2020
Q2 		$1K Buy
+14
New +$1.09K ﹤0.01% 2398

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SignatureFD's TXG Position: Q2 2026 in Review

SignatureFD reduced its 10x Genomics (TXG) stake by 3% in Q2 2026, selling an estimated $2.2K and leaving 2,697 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.

SignatureFD first reported a position in TXG in Q2 2020 and has held it in 24 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • SignatureFD held 2,697 shares of 10x Genomics worth $103K as of Q2 2026.
  • SignatureFD sold 84 10x Genomics shares in Q2 2026, an estimated $2.2K.
  • 10x Genomics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1424 holding.
  • SignatureFD first reported a position in 10x Genomics in Q2 2020 and has held it in 24 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.